Our Team


E. Russell McAllister

Chief Executive Officer
  • More than 15 years of biopharma industry experience, focusing on corporate strategy and business development
  • Current CEO, Intezyne (Oncology); Former CFO, Intezyne (Oncology); Qu Biologics (Immuno-oncology) and Lakewood-Amedex (Infectious disease)
  • 2018 CFO of the Year Honoree, Tampa Bay Business Journal (TBBJ)
  • 2017 ‘Deal of the Year’ recipient; Southeast Bio (SEBIO)
  • Former Managing Director, Head of Healthcare Strategic Advisory, H.C. Wainwright / Rodman & Renshaw
  • Former 5-Star-Rated Senior Equity Research Analyst (Biopharmaceuticals), Merriman Curhan Ford & Co. and Thomas Weisel Partners (Stifel)
  • PhD candidate, Behavioral Finance, University of Illinois; MS Accounting / MBA, Northeastern University


Jim Pankovich

Executive Vice President, Clinical Development
  • More than 25 years of biopharma industry experience, focusing on clinical study strategy and management
  • Former VP, Clinical Operations and Drug Development, Qu Biologics (Immuno-oncology); CSO, CIHR Canadian HIV Trial Network (Infectious disease); Sr Director, Clinical Research, Migenix (Infectious disease); Assc Director, Clinical Research, Inex Pharmaceuticals (Oncology)
  • MS, Experimental Medicine, University of Alberta; MBA, Queen’s University


Kevin Wong, CPA, CMA

Chief Financial Officer
  • More than 10 years of financial services experience, focusing on Asia-Pacific business development and finance
  • Former VP, National Life Sciences Practice, Deloitte Canada; Former Vice-President at CitiFinancial Canada
  • MS, Banking and Financial Mgmt, NEC
  • BGS Applied Sciences, Simon Fraser University


Melissa Smith

Executive Assistant